MANCHESTER, England, November 17, 2016 /PRNewswire/ --
Pharmas are set to benefit from insightful intelligence on asthma as Aerobit, provider of the Smart Respiratory Device, teams with leading Artificial Intelligence experts to unlock the potential of Big Data.
To more effectively manage asthma care, Aerobit has introduced a smart inhaler which tracks medication use and records each time an inhaler is taken by an asthma patient. Patients receive reminders and alerts for their prescribed medical regime. Doctors are able to track treatment progress and compliance.
In recognising the value of Big Data, Aerobit has teamed with leading Artificial Intelligence experts Eularis, to enable pharmaceuticals to gain a deeper understanding of patient needs, drug efficacy and adherence, and real world data to drive accelerated growth for asthma drugs.
Ali Moiyed, Aerobit chief executive said, "We are delighted to be working with Eularis. By combining our expertise, we are able to offer pharmas valuable intelligence relating to asthma. This offers great potential to guide product development and improve the quality of lives for the 5 million asthma sufferers within the UK alone."
Dr. Andrée Bates, President at Eularis, a leading expert in pharmaceutical Big Data analytics, states, "Our data partnership with Aerobit provides Pharma with accurate, real time, cutting-edge analytics that identify the real needs of asthma patients to enable informed strategic business decisions to deliver stronger outcomes for both the patients, and their own business results."
For more information visit: http://www.aerobithealth.com
Aerobit is building a smart platform of hardware and software, making managing asthma easier and more effective than ever. Our mission to be at the epicentre of improving Asthma care through a revolution in digital healthcare that puts patients at the centre of their care.
Media Relations: email@example.com
Eularis is the leading provider of next-generation advanced marketing analytics to the Pharmaceutical market. The machine learning based artificial intelligence powering Eularis analytics enables marketing, analytics and sales executives to achieve faster brand success. Since 2003 the company has developed significant experience in the global Pharmaceutical market through client engagements with Boehringer-Ingelheim, Merck, Pfizer, Roche, Shire, and many others. To learn more about Eularis, go to http://www.Eularis.com where you will be able to download a series of insights and resources.
Notes to Editor:
Photographs to support the press release can be requested via: firstname.lastname@example.org.
SOURCE Aerobit Health LTD